Asia Spotlight: Innovative, Differentiated Generics To Lead Merck Into Emerging Markets, Says EM President Kevin Ali
Executive Summary
MUMBAI – Merck & Co. President for Emerging Markets Kevin Ali likes to understand the “ground feel” of a company, says a senior company executive at its India affiliate MSD, and that need to see things in person may have brought the busy executive trotting back to India in less than three months of signing a “transformative deal” with Sun Pharmaceutical Industries Ltd.